drugset / Trial / NCT01438710

Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)

NCT01438710

Phase 3 Completed 44 enrolled Veloxis Pharmaceuticals
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate and measure symptomatic hand tremor in stable kidney transplant subjects on Prograf or generic tacrolimus maintenance therapy at baseline (pre-conversion) and following conversion to LCP-Tacro. This study will also evaluate the safety of LCP-Tacro compared with Prograf or generic tacrolimus

Timeline

Start
2011-12
Primary completion
2012-08
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule Oral

Indications